[go: up one dir, main page]

ITUB20152881A1 - Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions. - Google Patents

Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions.

Info

Publication number
ITUB20152881A1
ITUB20152881A1 ITUB2015A002881A ITUB20152881A ITUB20152881A1 IT UB20152881 A1 ITUB20152881 A1 IT UB20152881A1 IT UB2015A002881 A ITUB2015A002881 A IT UB2015A002881A IT UB20152881 A ITUB20152881 A IT UB20152881A IT UB20152881 A1 ITUB20152881 A1 IT UB20152881A1
Authority
IT
Italy
Prior art keywords
monascus
polyunsaturated
extracts
prevention
combinations
Prior art date
Application number
ITUB2015A002881A
Other languages
Italian (it)
Inventor
Claudio Franco Omini
Marco Raffaele Galbiati
Arrigo Aldo Gandolfi
Gabriele Omini
Original Assignee
Omini Pharma Srls
Gabriele Omini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omini Pharma Srls, Gabriele Omini filed Critical Omini Pharma Srls
Priority to ITUB2015A002881A priority Critical patent/ITUB20152881A1/en
Publication of ITUB20152881A1 publication Critical patent/ITUB20152881A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
ITUB2015A002881A 2015-08-05 2015-08-05 Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions. ITUB20152881A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUB2015A002881A ITUB20152881A1 (en) 2015-08-05 2015-08-05 Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A002881A ITUB20152881A1 (en) 2015-08-05 2015-08-05 Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions.

Publications (1)

Publication Number Publication Date
ITUB20152881A1 true ITUB20152881A1 (en) 2017-02-05

Family

ID=54705704

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2015A002881A ITUB20152881A1 (en) 2015-08-05 2015-08-05 Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions.

Country Status (1)

Country Link
IT (1) ITUB20152881A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009027753A1 (en) * 2007-08-27 2009-03-05 Feher Janos Composition and method inhibiting inflammation
WO2012012372A1 (en) * 2010-07-21 2012-01-26 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009027753A1 (en) * 2007-08-27 2009-03-05 Feher Janos Composition and method inhibiting inflammation
WO2012012372A1 (en) * 2010-07-21 2012-01-26 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CICERO ARRIGO F G ET AL: "Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study", JOURNAL OF MEDICINAL FOOD, vol. 18, no. 11, November 2015 (2015-11-01), pages 1270 - 1273, XP055261196 *
SHEN-SHIH CHIANG ET AL: "Osteoprotective Effect of Monascus -fermented Dioscorea in Ovariectomized Rat Model of Postmenopausal Osteoporosis", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 59, no. 17, 31 July 2011 (2011-07-31), US, pages 9150 - 9157, XP055261192, ISSN: 0021-8561, DOI: 10.1021/jf201640j *
XUE-MEI LI ET AL: "Advances on the Pharmacological Effects of Red Yeast Rice", ZHONGGUO TIANRAN YAOWU - CHINESE JOURNAL OF NATURAL MEDICINES, ZHONGGUO TIANRAN YAOWU, NANJING, CN, vol. 9, no. 3, 17 May 2011 (2011-05-17), pages 161 - 166, XP002685340, ISSN: 1672-3651, DOI: 10.3724/SP.J.1009.2011.00161 *
Y.F. WANG ET AL: "Anti-osteoporosis activity of red yeast rice extract on ovariectomy-induced bone loss in rats", GENETICS AND MOLECULAR RESEARCH, vol. 14, no. 3, 27 July 2015 (2015-07-27), BR, pages 8137 - 8146, XP055261217, ISSN: 1676-5680, DOI: 10.4238/2015.July.27.2 *
YOUNG-EUN CHO ET AL: "Red yeast rice stimulates osteoblast proliferation and increases alkaline phosphatase activity in MC3T3-E1 cells", NUTRITION RESEARCH., vol. 30, no. 7, 1 July 2010 (2010-07-01), XX, pages 501 - 510, XP055261194, ISSN: 0271-5317, DOI: 10.1016/j.nutres.2010.06.011 *

Similar Documents

Publication Publication Date Title
PL3889145T3 (en) 8-cyano-5-piperidine-quinolines as TLR7/8 antagonists and their use in the treatment of immunological disorders
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
PL3896064T3 (en) 4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS COT MODULATORS IN THE TREATMENT OF CROOHN'S DISEASE AND ULTRASPECTRUM COLITIS
SG11201912103TA (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
PL3381451T3 (en) PHARMACEUTICAL COMPOSITION USED FOR REDUCTION OF LOCALIZED ADIPOSITE TISSUES AND USE OF THE PHARMACEUTICAL COMPOSITION
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
SG11201803022TA (en) Compositions comprising fatty acids and their use
EP3458079A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACNE
BR112017007748A2 (en) “PHARMACEUTICAL COMPOSITION, ANTIALERGIC AGENT, FOOD COMPOSITION, COSMETIC COMPOSITION, USE OF AN EXTRACT, AND, METHOD TO PREVENT OR TREAT AN ALLERGIC DISEASE
CY1123942T1 (en) OMEGA-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISEASES CAUSING DAMAGE TO THE NERVOUS SYSTEM
MA52644A (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF DGLA ACID AND THEIR USE
HUE060882T2 (en) Naphthyridinone derivatives and their use in the treatment of arrhythmia
IT201700085412A1 (en) Composition for use in the prevention and treatment of cardiovascular diseases
ZA202103827B (en) Liquid hand dishwash formulation comprising fatty acids and polymer
IL271961A (en) Compositions comprising thymoquinone and omega-3 fatty acids
ES2699722R1 (en) COMPOSITION TO TREAT DISEASES OF THE MOTOR NEURONS AND USE OF THE SAME
SG11201912098SA (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
EP2968209A4 (en) NANOPARTICULAR FORMULATIONS OF METADICHOL R IN THE FORM OF LIQUID AND GEL
EP3322408A4 (en) NEW FORMULATION FOR THE ELIMINATION OF CARIOGEN AND OPPORTUNISTIC PATHOGENS IN THE ORAL CAVITY
PT3413870T (en) IGMESIN FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
ITUB20152881A1 (en) Use of combinations of essential fatty acids (polyunsaturated? 3 /? 6) and Monascus extracts in the prevention and treatment of cartilage lesions.
BR112017007754A2 (en) monounsaturated fatty acid compositions and use for the treatment of atherosclerosis.
FR3034667B1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST ACNE
FR3072972B1 (en) METHOD FOR THE IN VITRO PREPARATION OF DERMAL PAPILLA AND HAIR FOLLICLE EQUIVALENTS
EP3362085A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INVOLVING MUCIN